# Dexlansoprazole

NDC: 46708-823
Generic name: Dexlansoprazole
Labeler / Manufacturer: Alembic Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, DELAYED RELEASE
Routes: ORAL
Marketing started: 20251114

FDA application: ANDA219115

## Active ingredients

- DEXLANSOPRAZOLE: 30 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"46708-823"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=46708-823
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24c33ba6-bf47-434e-903e-f7ced98e030e